A Multicenter, Double Blind, Comparative Study of Zidovudine Alone Versus Zidovudine and Acyclovir as Treatment for HIV-Infected Patients With CD4+ Counts Less Than 200 Cells/mm3
Clinical trial NCT00000712 · COMPLETED
Trial details
- NCT number
- NCT00000712
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.